We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
-1.45%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.91B
AUM Growth
-$58.7M
Cap. Flow
-$6.54M
Cap. Flow %
-0.34%
Top 10 Hldgs %
39.91%
Holding
252
New
15
Increased
80
Reduced
73
Closed
17

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$5.48M
2
MS icon
Morgan Stanley
MS
+$5.37M
3
PFE icon
Pfizer
PFE
+$4.76M
4
FAST icon
Fastenal
FAST
+$4.66M
5
TGT icon
Target
TGT
+$4.36M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$14.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$11.8M
3
DIS icon
Walt Disney
DIS
+$8.48M
4
LMT icon
Lockheed Martin
LMT
+$6.84M
5
TRV icon
Travelers Companies
TRV
+$3.24M

Sector Composition

Rank Sector Weight
1 Consumer Staples 24.07%
2 Technology 21.25%
3 Healthcare 12.53%
4 Financials 11.18%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
1
Walmart Inc
WMT
$893B
$273M 14.33%
5,500,671
-307,920
-5% -$14.5M
AAPL icon
2
Apple
AAPL
$4.8T
$105M 5.53%
603,726
+10,486
+2% +$1.76M
KO icon
3
Coca-Cola
KO
$353B
$82.5M 4.33%
1,330,233
-10,870
-0.8% -$661K
MSFT icon
4
Microsoft
MSFT
$2.99T
$69.1M 3.63%
224,090
+1,485
+0.7% +$447K
SPGI icon
5
S&P Global
SPGI
$133B
$51.7M 2.71%
126,000
AMGN icon
6
Amgen
AMGN
$197B
$48.2M 2.53%
199,118
+1,617
+0.8% +$372K
PG icon
7
Procter & Gamble
PG
$347B
$44.3M 2.32%
289,726
-12,126
-4% -$1.9M
JNJ icon
8
Johnson & Johnson
JNJ
$599B
$33.1M 1.73%
186,491
+5,625
+3% +$957K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.3T
$27.8M 1.46%
199,680
+540
+0.3% +$73.3K
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$122B
$25.7M 1.35%
98,316
-594
-0.6% -$141K
XOM icon
11
ExxonMobil
XOM
$615B
$24.2M 1.27%
292,709
-18,156
-6% -$1.41M
CVX icon
12
Chevron
CVX
$378B
$23.3M 1.22%
143,328
-21,537
-13% -$3.09M
JPM icon
13
JPMorgan Chase
JPM
$901B
$23.2M 1.22%
170,159
+14,438
+9% +$2.13M
MCD icon
14
McDonald's
MCD
$190B
$21.8M 1.14%
88,024
+4,109
+5% +$1.02M
AXP icon
15
American Express
AXP
$240B
$21.6M 1.13%
115,581
+3,036
+3% +$548K
TXN icon
16
Texas Instruments
TXN
$259B
$21.3M 1.12%
116,025
+6,238
+6% +$1.1M
CSCO icon
17
Cisco
CSCO
$436B
$21.1M 1.11%
377,720
+20,962
+6% +$1.19M
CMCSA icon
18
Comcast
CMCSA
$84.9B
$21M 1.1%
448,598
+65,050
+17% +$3.13M
EA icon
19
Electronic Arts
EA
$52.5B
$20.8M 1.09%
164,526
+6,804
+4% +$885K
AMZN icon
20
Amazon
AMZN
$2.69T
$20.6M 1.08%
126,440
-540
-0.4% -$83.4K
PAYX icon
21
Paychex
PAYX
$41B
$19.9M 1.05%
146,112
+5,245
+4% +$644K
LOW icon
22
Lowe's Companies
LOW
$115B
$19.8M 1.04%
98,035
+8,446
+9% +$1.94M
VZ icon
23
Verizon
VZ
$182B
$19.6M 1.03%
384,088
+44,337
+13% +$2.35M
ABBV icon
24
AbbVie
ABBV
$448B
$19M 1%
117,146
-10,297
-8% -$1.5M
AFL icon
25
Aflac
AFL
$63.2B
$17.9M 0.94%
278,277
+24,759
+10% +$1.55M

Similar funds

Cullinan Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Cullinan Associates held 252 positions worth $1.91B, down 3% from $1.96B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cullinan Associates's Q1 2022 filing shows 15 new, 80 increased, 73 reduced and 17 closed positions. Its largest new stake was West Pharmaceutical: 14,000 shares worth $5.75M. The largest sale was Walmart Inc, an estimated $14.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q1 2022 buy was West Pharmaceutical: 14,000 shares worth $5.75M.
  • Cullinan Associates added most to Morgan Stanley in Q1 2022, an estimated $5.37M increase.
  • Cullinan Associates's biggest Q1 2022 reduction was Walmart Inc, cutting an estimated $14.5M.
  • Cullinan Associates fully exited Vontier in Q1 2022, selling an estimated $758K.
  • Cullinan Associates's ten largest holdings make up 40% of its $1.91B portfolio in Q1 2022.
  • Cullinan Associates opened 15 new positions and closed 17 in Q1 2022.
  • Cullinan Associates's portfolio value fell 3% quarter-over-quarter to $1.91B.

Based on Cullinan Associates's 13F filing for Q1 2022, filed 21 Apr 2022.